Becton, Dickinson and Company (BDX) Stock Forecast, Price Target & Predictions
BDX Stock Forecast
Becton, Dickinson and Company stock forecast is as follows: an average price target of $283.27 (represents a 18.91% upside from BDX’s last price of $238.22) and a rating consensus of 'Buy', based on 11 wall street analysts offering a 1-year stock forecast.
BDX Price Target
BDX Analyst Ratings
Becton, Dickinson and Company Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 01, 2024 | Vijay Kumar | Evercore ISI | $290.00 | $241.10 | 20.28% | 21.74% |
Oct 01, 2024 | Joanna Wuensch | Citigroup | $275.00 | $241.93 | 13.67% | 15.44% |
Aug 02, 2024 | Jayson Bedford | Raymond James | $270.00 | $239.09 | 12.93% | 13.34% |
Aug 02, 2024 | Larry Biegelsen | Wells Fargo | $280.00 | $236.01 | 18.64% | 17.54% |
Jul 02, 2024 | Becton Dickinson | Evercore ISI | $285.00 | $229.27 | 24.31% | 19.64% |
May 30, 2024 | David Roman | Goldman Sachs | $274.00 | $225.07 | 21.74% | 15.02% |
May 06, 2024 | Matt Miksic | Barclays | $312.00 | $234.68 | 32.95% | 30.97% |
Apr 08, 2024 | David Toung | Argus Research | $300.00 | $242.73 | 23.59% | 25.93% |
Jan 06, 2023 | - | Morgan Stanley | $290.00 | $258.12 | 12.35% | 21.74% |
Dec 12, 2022 | - | Citigroup | $250.00 | $247.60 | 0.97% | 4.95% |
Becton, Dickinson and Company Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 2 | 4 | 8 |
Avg Price Target | $282.50 | $278.75 | $285.75 |
Last Closing Price | $238.22 | $238.22 | $238.22 |
Upside/Downside | 18.59% | 17.01% | 19.95% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 01, 2024 | Evercore ISI | Outperform | Outperform | Hold |
Oct 01, 2024 | Citigroup | Neutral | Buy | Upgrade |
Aug 02, 2024 | Raymond James | Outperform | Outperform | Hold |
Aug 02, 2024 | Wells Fargo | Overweight | Overweight | Hold |
Jul 10, 2024 | Citigroup | Neutral | Neutral | Hold |
May 23, 2024 | CFRA | - | Buy | Upgrade |
May 06, 2024 | Barclays | Overweight | Overweight | Hold |
Apr 04, 2024 | Citigroup | Neutral | Neutral | Hold |
Feb 01, 2024 | William Blair | Positive | Positive | Hold |
Aug 21, 2023 | Citigroup | Neutral | Neutral | Hold |
Becton, Dickinson and Company Financial Forecast
Becton, Dickinson and Company Revenue Forecast
Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | $4.71B | $5.09B | $4.88B | $4.82B | $4.59B | $4.76B | - | $5.01B | $5.00B | $5.13B | $4.89B | $4.91B | $5.32B | $4.78B | $3.85B | $4.25B | $4.22B | $4.58B | $4.35B |
Avg Forecast | $5.97B | $5.67B | $5.64B | $5.29B | $5.73B | $5.46B | $5.43B | $5.11B | $5.36B | $5.08B | $5.04B | $4.73B | $5.02B | $4.84B | $4.69B | $4.53B | $4.71B | $4.47B | $4.85B | $4.76B | $4.91B | $4.51B | $4.89B | $4.92B | $4.48B | $3.94B | $4.16B | $4.18B | $4.56B | $4.36B |
High Forecast | $5.97B | $5.67B | $5.64B | $5.29B | $5.73B | $5.46B | $5.43B | $5.11B | $5.37B | $5.08B | $5.04B | $4.76B | $5.07B | $4.84B | $4.69B | $4.53B | $4.71B | $4.47B | $4.88B | $4.80B | $4.94B | $4.54B | $4.92B | $4.95B | $4.51B | $3.97B | $4.19B | $4.21B | $4.59B | $4.39B |
Low Forecast | $5.97B | $5.67B | $5.64B | $5.29B | $5.73B | $5.46B | $5.43B | $5.11B | $5.35B | $5.08B | $5.04B | $4.68B | $4.98B | $4.84B | $4.69B | $4.53B | $4.71B | $4.47B | $4.81B | $4.72B | $4.87B | $4.47B | $4.85B | $4.87B | $4.45B | $3.91B | $4.13B | $4.15B | $4.52B | $4.32B |
# Analysts | 4 | 4 | 6 | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 8 | 11 | 5 | 9 | 5 | 4 | 4 | 3 | 4 | 8 | 5 | 4 | 6 | 4 | 6 | 4 | 5 | 3 | 5 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 1.01% | 1.01% | 1.03% | 1.01% | 1.01% | - | 1.03% | 1.05% | 1.05% | 1.09% | 1.00% | 1.08% | 1.07% | 0.98% | 1.02% | 1.01% | 1.00% | 1.00% |
Becton, Dickinson and Company EBITDA Forecast
Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 6 | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 8 | 11 | 5 | 9 | 5 | 4 | 4 | 3 | 4 | 8 | 5 | 4 | 6 | 4 | 6 | 4 | 5 | 3 | 5 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | $439.00M | $1.02B | $549.00M | $1.27B | $1.19B | $499.00M | - | $1.21B | $1.38B | $969.00M | $1.20B | $987.00M | $1.83B | $819.00M | $917.00M | $871.00M | $1.06B | $692.00M | $1.19B |
Avg Forecast | $1.48B | $1.40B | $1.40B | $1.31B | $1.42B | $1.35B | $1.34B | $1.26B | $1.33B | $1.26B | $1.34B | $1.17B | $1.24B | $1.20B | $1.22B | $1.10B | $1.17B | $1.11B | $1.11B | $996.03M | $905.20M | $1.07B | $938.30M | $1.08B | $731.25M | $845.08M | $784.65M | $1.05B | $689.90M | $1.18B |
High Forecast | $1.48B | $1.40B | $1.40B | $1.31B | $1.42B | $1.35B | $1.34B | $1.26B | $1.33B | $1.26B | $1.61B | $1.18B | $1.25B | $1.20B | $1.46B | $1.31B | $1.17B | $1.11B | $1.33B | $1.20B | $1.09B | $1.28B | $1.13B | $1.30B | $877.50M | $1.01B | $941.58M | $1.26B | $827.88M | $1.41B |
Low Forecast | $1.48B | $1.40B | $1.40B | $1.31B | $1.42B | $1.35B | $1.34B | $1.26B | $1.32B | $1.26B | $1.07B | $1.16B | $1.23B | $1.20B | $974.89M | $876.50M | $1.17B | $1.11B | $886.26M | $796.82M | $724.16M | $856.40M | $750.64M | $864.75M | $585.00M | $676.06M | $627.72M | $842.35M | $551.92M | $942.64M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.37% | 0.82% | 0.46% | 1.04% | 1.09% | 0.43% | - | 1.09% | 1.38% | 1.07% | 1.12% | 1.05% | 1.69% | 1.12% | 1.09% | 1.11% | 1.01% | 1.00% | 1.01% |
Becton, Dickinson and Company Net Income Forecast
Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 6 | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 8 | 11 | 5 | 9 | 5 | 4 | 4 | 3 | 4 | 8 | 5 | 4 | 6 | 4 | 6 | 4 | 5 | 3 | 5 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | $281.00M | $108.00M | $407.00M | $460.00M | $509.00M | $287.00M | - | $454.00M | $677.00M | $265.00M | $525.00M | $299.00M | $1.00B | $128.00M | $286.00M | $183.00M | $278.00M | $162.00M | $451.00M |
Avg Forecast | $1.28B | $1.15B | $1.09B | $966.54M | $1.18B | $1.06B | $1.02B | $889.91M | $1.09B | $960.30M | $514.43M | $696.63M | $994.11M | $845.63M | $467.67M | $538.27M | $796.03M | $725.31M | $425.15M | $489.34M | $247.55M | $465.24M | $284.25M | $592.45M | $114.29M | $263.57M | $164.86M | $275.89M | $161.51M | $446.56M |
High Forecast | $1.28B | $1.15B | $1.09B | $966.54M | $1.18B | $1.06B | $1.02B | $889.91M | $1.11B | $960.30M | $617.32M | $702.46M | $1.02B | $845.63M | $561.20M | $645.93M | $796.03M | $725.31M | $510.18M | $587.21M | $297.06M | $558.29M | $341.10M | $710.94M | $137.14M | $316.28M | $197.83M | $331.06M | $193.81M | $535.88M |
Low Forecast | $1.28B | $1.15B | $1.09B | $966.54M | $1.18B | $1.06B | $1.02B | $889.91M | $1.09B | $960.30M | $411.55M | $690.81M | $962.23M | $845.63M | $374.13M | $430.62M | $796.03M | $725.31M | $340.12M | $391.47M | $198.04M | $372.20M | $227.40M | $473.96M | $91.43M | $210.85M | $131.89M | $220.71M | $129.21M | $357.25M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.40% | 0.11% | 0.48% | 0.98% | 0.95% | 0.36% | - | 1.07% | 1.38% | 1.07% | 1.13% | 1.05% | 1.69% | 1.12% | 1.09% | 1.11% | 1.01% | 1.00% | 1.01% |
Becton, Dickinson and Company SG&A Forecast
Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 6 | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 8 | 11 | 5 | 9 | 5 | 4 | 4 | 3 | 4 | 8 | 5 | 4 | 6 | 4 | 6 | 4 | 5 | 3 | 5 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | $1.21B | $1.14B | $1.19B | $1.21B | $1.19B | $1.18B | - | $1.23B | $1.22B | $1.33B | $1.24B | $1.15B | $1.15B | $1.19B | $980.00M | $1.02B | $1.12B | $1.10B | $1.08B |
Avg Forecast | $1.48B | $1.40B | $1.40B | $1.31B | $1.42B | $1.35B | $1.34B | $1.26B | $1.33B | $1.26B | $1.40B | $1.17B | $1.24B | $1.20B | $1.27B | $972.39M | $1.16B | $1.11B | $1.15B | $883.99M | $1.25B | $1.10B | $1.09B | $678.69M | $1.06B | $903.14M | $2.86B | $1.11B | $1.09B | $1.07B |
High Forecast | $1.48B | $1.40B | $1.40B | $1.31B | $1.42B | $1.35B | $1.34B | $1.26B | $1.33B | $1.26B | $1.68B | $1.18B | $1.25B | $1.20B | $1.52B | $1.17B | $1.16B | $1.11B | $1.38B | $1.06B | $1.49B | $1.32B | $1.31B | $814.42M | $1.28B | $1.08B | $3.43B | $1.33B | $1.31B | $1.28B |
Low Forecast | $1.48B | $1.40B | $1.40B | $1.31B | $1.42B | $1.35B | $1.34B | $1.26B | $1.32B | $1.26B | $1.12B | $1.16B | $1.23B | $1.20B | $1.02B | $777.91M | $1.16B | $1.11B | $922.97M | $707.19M | $996.18M | $876.96M | $873.08M | $542.95M | $851.43M | $722.51M | $2.29B | $889.98M | $874.14M | $852.33M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 1.04% | 0.92% | 0.99% | 0.95% | 1.22% | 1.01% | - | 1.07% | 1.38% | 1.07% | 1.13% | 1.05% | 1.69% | 1.12% | 1.09% | 0.36% | 1.01% | 1.00% | 1.01% |
Becton, Dickinson and Company EPS Forecast
Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 6 | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 8 | 11 | 5 | 9 | 5 | 4 | 4 | 3 | 4 | 8 | 5 | 4 | 6 | 4 | 6 | 4 | 5 | 3 | 5 |
EPS | - | - | - | - | - | - | - | - | - | - | - | $0.97 | $0.37 | $1.42 | $1.54 | $1.71 | $0.93 | - | $1.51 | $2.38 | $0.85 | $1.73 | $0.95 | $3.38 | $0.36 | $0.98 | $0.53 | $0.88 | $0.41 | $1.53 |
Avg Forecast | $4.42 | $3.95 | $3.76 | $3.33 | $4.06 | $3.66 | $3.50 | $3.07 | $3.77 | $3.31 | $2.97 | $2.40 | $3.42 | $2.91 | $2.74 | $2.68 | $2.74 | $2.50 | $2.93 | $2.78 | $2.39 | $2.39 | $2.96 | $3.04 | $2.46 | $1.98 | $2.32 | $2.56 | $3.22 | $2.97 |
High Forecast | $4.42 | $3.95 | $3.76 | $3.33 | $4.06 | $3.66 | $3.50 | $3.07 | $3.83 | $3.31 | $2.97 | $2.42 | $3.51 | $2.91 | $2.74 | $2.68 | $2.74 | $2.50 | $2.95 | $2.81 | $2.41 | $2.41 | $2.99 | $3.07 | $2.48 | $2.00 | $2.34 | $2.58 | $3.25 | $3.00 |
Low Forecast | $4.42 | $3.95 | $3.76 | $3.33 | $4.06 | $3.66 | $3.50 | $3.07 | $3.74 | $3.31 | $2.97 | $2.38 | $3.32 | $2.91 | $2.74 | $2.68 | $2.74 | $2.50 | $2.90 | $2.75 | $2.37 | $2.36 | $2.93 | $3.01 | $2.43 | $1.96 | $2.30 | $2.53 | $3.18 | $2.94 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.40% | 0.11% | 0.49% | 0.56% | 0.64% | 0.34% | - | 0.52% | 0.86% | 0.36% | 0.72% | 0.32% | 1.11% | 0.15% | 0.50% | 0.23% | 0.34% | 0.13% | 0.52% |
Becton, Dickinson and Company Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
COO | Cooper Companies | $105.92 | $298.00 | 181.34% | Buy |
ANGO | AngioDynamics | $6.10 | $15.00 | 145.90% | Buy |
XRAY | DENTSPLY SIRONA | $25.22 | $40.00 | 58.60% | Hold |
RGEN | Repligen | $136.71 | $189.50 | 38.61% | Buy |
HAE | Haemonetics | $77.89 | $104.33 | 33.95% | Buy |
TFX | Teleflex | $239.18 | $304.09 | 27.14% | Buy |
BDX | Becton, Dickinson and Company | $238.22 | $283.27 | 18.91% | Buy |
WST | West Pharmaceutical Services | $296.50 | $345.33 | 16.47% | Buy |
HOLX | Hologic | $80.24 | $80.43 | 0.24% | Buy |
ALC | Alcon | $97.27 | $93.34 | -4.04% | Buy |
RMD | ResMed | $233.98 | $219.13 | -6.35% | Hold |
ICUI | ICU Medical | $179.20 | $135.00 | -24.67% | Buy |
BDX Forecast FAQ
Is Becton, Dickinson and Company a good buy?
Yes, according to 11 Wall Street analysts, Becton, Dickinson and Company (BDX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 11 'Buy' recommendations, accounting for 100.00% of BDX's total ratings.
What is BDX's price target?
Becton, Dickinson and Company (BDX) average price target is $283.27 with a range of $255 to $312, implying a 18.91% from its last price of $238.22. The data is based on 11 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Becton, Dickinson and Company stock go up soon?
According to Wall Street analysts' prediction for BDX stock, the company can go up by 18.91% (from the last price of $238.22 to the average price target of $283.27), up by 30.97% based on the highest stock price target, and up by 7.04% based on the lowest stock price target.
Can Becton, Dickinson and Company stock reach $400?
BDX's average twelve months analyst stock price target of $283.27 does not support the claim that Becton, Dickinson and Company can reach $400 in the near future.
What is Becton, Dickinson and Company's current price target trend?
2 Wall Street analysts forecast a $282.5 price target for Becton, Dickinson and Company (BDX) this month, up 18.59% from its last price of $238.22. Compared to the last 3 and 12 months, the average price target increased by 17.01% and increased by 19.95%, respectively.
What are Becton, Dickinson and Company's analysts' financial forecasts?
Becton, Dickinson and Company's analysts financial forecasts for the fiscal year (Sep 2025) are as follows: average revenue is $21.73B (high $21.73B, low $21.73B), average EBITDA is $5.38B (high $5.38B, low $5.38B), average net income is $4.15B (high $4.15B, low $4.15B), average SG&A $5.37B (high $5.37B, low $5.37B), and average EPS is $14.29 (high $14.29, low $14.29). BDX's analysts financial forecasts for the fiscal year (Sep 2026) are as follows: average revenue is $22.57B (high $22.57B, low $22.57B), average EBITDA is $5.59B (high $5.59B, low $5.59B), average net income is $4.49B (high $4.49B, low $4.49B), average SG&A $5.58B (high $5.58B, low $5.58B), and average EPS is $15.46 (high $15.46, low $15.46).
Did the BDX's actual financial results beat the analysts' financial forecasts?
Based on Becton, Dickinson and Company's last annual report (Sep 2023), the company's revenue was $19.37B, beating the average analysts forecast of $19.08B by 1.54%. Apple's EBITDA was $4.72B, missing the average prediction of $4.75B by -0.81%. The company's net income was $1.48B, missing the average estimation of $2.85B by -47.85%. Apple's SG&A was $4.72B, beating the average forecast of $4.68B by 0.83%. Lastly, the company's EPS was $4.97, missing the average prediction of $11.76 by -57.73%. In terms of the last quarterly report (Dec 2023), Becton, Dickinson and Company's revenue was $4.71B, missing the average analysts' forecast of $4.73B by -0.56%. The company's EBITDA was $439M, missing the average prediction of $1.17B by -62.51%. Becton, Dickinson and Company's net income was $281M, missing the average estimation of $696.63M by -59.66%. The company's SG&A was $1.21B, beating the average forecast of $1.17B by 3.63%. Lastly, the company's EPS was $0.97, missing the average prediction of $2.4 by -59.58%